Cathelicidin Antimicrobial Peptides Block Dendritic Cell TLR4 Activation and Allergic Contact Sensitization1

Cathelicidins are antimicrobial peptides of the innate immune system that establish an antimicrobial barrier at epithelial interfaces and have been proposed to have a proinflammatory function. We studied the role of cathelicidin in allergic contact dermatitis, a model requiring dendritic cells of the innate immune response and T cells of the adaptive immune response. Deletion of the murine cathelicidin gene Cnlp enhanced an allergic contact response, whereas local administration of cathelicidin before sensitization inhibited the allergic response. Cathelicidins inhibited TLR4 but not TLR2 mediated induction of dendritic cell maturation and cytokine release, and this inhibition was associated with an alteration of cell membrane function and structure. Further analysis in vivo connected these observations because inhibition of sensitization by exogenous cathelicidin was dependent on the presence of functional TLR4. These observations provide evidence that cathelicidin antimicrobial peptides mediate an anti-inflammatory response in part by their activity at the membrane.

[1]  Fiona S. L. Brinkman,et al.  Modulation of the TLR-Mediated Inflammatory Response by the Endogenous Human Host Defense Peptide LL-371 , 2006, The Journal of Immunology.

[2]  P. Askenase,et al.  TLR-Dependent IL-4 Production by Invariant Vα14+Jα18+ NKT Cells to Initiate Contact Sensitivity In Vivo1 , 2005, The Journal of Immunology.

[3]  F. Yarovinsky,et al.  Mouse Cathelin-Related Antimicrobial Peptide Chemoattracts Leukocytes Using Formyl Peptide Receptor-Like 1/Mouse Formyl Peptide Receptor-Like 2 as the Receptor and Acts as an Immune Adjuvant1 , 2005, The Journal of Immunology.

[4]  R. Gallo,et al.  Structure-Function Relationships among Human Cathelicidin Peptides: Dissociation of Antimicrobial Properties from Host Immunostimulatory Activities , 2005, The Journal of Immunology.

[5]  T. Ohtake,et al.  Expression of an additional cathelicidin antimicrobial peptide protects against bacterial skin infection. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[6]  M. Jadot,et al.  Cholesterol depletion upregulates involucrin expression in epidermal keratinocytes through activation of p38. , 2004, The Journal of investigative dermatology.

[7]  Sébastien Roy,et al.  Mast cell- and dendritic cell-derived exosomes display a specific lipid composition and an unusual membrane organization. , 2004, The Biochemical journal.

[8]  J. Simon,et al.  Hyaluronan Fragments Stimulate Endothelial Recognition of Injury through TLR4* , 2004, Journal of Biological Chemistry.

[9]  M. Wewers,et al.  A Novel P2X7 Receptor Activator, the Human Cathelicidin-Derived Peptide LL37, Induces IL-1β Processing and Release1 , 2004, The Journal of Immunology.

[10]  R. Hancock,et al.  The Human Cationic Peptide LL-37 Induces Activation of the Extracellular Signal-Regulated Kinase and p38 Kinase Pathways in Primary Human Monocytes1 , 2004, The Journal of Immunology.

[11]  B. Finlay,et al.  Interplay between antibacterial effectors: a macrophage antimicrobial peptide impairs intracellular Salmonella replication. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[12]  R. Hancock,et al.  The Cationic Antimicrobial Peptide LL-37 Modulates Dendritic Cell Differentiation and Dendritic Cell-Induced T Cell Polarization , 2004, The Journal of Immunology.

[13]  P. Askenase,et al.  Cutaneous Immunization Rapidly Activates Liver Invariant Vα14 NKT Cells Stimulating B-1 B Cells to Initiate T Cell Recruitment for Elicitation of Contact Sensitivity , 2003, The Journal of experimental medicine.

[14]  L. Kwak,et al.  Roles of antimicrobial peptides such as defensins in innate and adaptive immunity , 2003, Annals of the rheumatic diseases.

[15]  K. Fukase,et al.  Lipopolysaccharide Interaction with Cell Surface Toll-like Receptor 4-MD-2 , 2003, The Journal of experimental medicine.

[16]  I. Nagaoka,et al.  Epithelial cell-derived antibacterial peptides human beta-defensins and cathelicidin: multifunctional activities on mast cells. , 2003, Current drug targets. Inflammation and allergy.

[17]  J. Abastado,et al.  Composition of MHC class II‐enriched lipid microdomains is modified during maturation of primary dendritic cells , 2003, Journal of leukocyte biology.

[18]  J. Bluestone,et al.  Altered cutaneous immune parameters in transgenic mice overexpressing viral IL-10 in the epidermis. , 2003, The Journal of clinical investigation.

[19]  N. Salzman,et al.  Protection against enteric salmonellosis in transgenic mice expressing a human intestinal defensin , 2003, Nature.

[20]  A. Vitiello,et al.  Cutting Edge: Mast Cell Antimicrobial Activity Is Mediated by Expression of Cathelicidin Antimicrobial Peptide 1 , 2003, The Journal of Immunology.

[21]  C. Ross,et al.  Tissue hypoxia during bacterial sepsis is attenuated by PR-39, an antibacterial peptide. , 2003, Advances in experimental medicine and biology.

[22]  Göran Carlsson,et al.  Deficiency of antibacterial peptides in patients with morbus Kostmann: an observation study , 2002, The Lancet.

[23]  Tomas Ganz,et al.  Endogenous antimicrobial peptides and skin infections in atopic dermatitis. , 2002, The New England journal of medicine.

[24]  J. Wagner,et al.  Catecholamines Inhibit the Antigen-Presenting Capability of Epidermal Langerhans Cells1 , 2002, The Journal of Immunology.

[25]  K. Iwabuchi,et al.  A cathelicidin family of human antibacterial peptide LL‐37 induces mast cell chemotaxis , 2002, Immunology.

[26]  A. Vitiello,et al.  Ex vivo priming for long-term maintenance of antileukemia human cytotoxic T cells suggests a general procedure for adoptive immunotherapy. , 2001, Blood.

[27]  Takaaki Ohtake,et al.  Innate antimicrobial peptide protects the skin from invasive bacterial infection , 2001, Nature.

[28]  J. Calafat,et al.  Human cathelicidin, hCAP-18, is processed to the antimicrobial peptide LL-37 by extracellular cleavage with proteinase 3. , 2001, Blood.

[29]  O. Chertov,et al.  Participation of mammalian defensins and cathelicidins in anti‐microbial immunity: receptors and activities of human defensins and cathelicidin (LL‐37) , 2001, Journal of leukocyte biology.

[30]  T. Ganz,et al.  Inhibition of neutrophil elastase prevents cathelicidin activation and impairs clearance of bacteria from wounds. , 2001, Blood.

[31]  Ji Ming Wang,et al.  Ll-37, the Neutrophil Granule–And Epithelial Cell–Derived Cathelicidin, Utilizes Formyl Peptide Receptor–Like 1 (Fprl1) as a Receptor to Chemoattract Human Peripheral Blood Neutrophils, Monocytes, and T Cells , 2000, The Journal of experimental medicine.

[32]  S. Grabbe,et al.  Immunoregulatory mechanisms involved in elicitation of allergic contact hypersensitivity. , 1996, Immunology today.

[33]  C. Ross,et al.  PR-39, a proline-rich antibacterial peptide that inhibits phagocyte NADPH oxidase activity by binding to Src homology 3 domains of p47 phox. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[34]  F. Sallusto,et al.  Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha , 1994, The Journal of experimental medicine.